Harvard Bioscience (HBIO) experienced a significant stock price increase of 5.56%, reaching $2.28 per share. The trading volume recorded was 120,363 shares with
Revenue: $2.5 million for Q3 2024, a 22% increase year-over-year.International Revenue: $1.3 million for Q3 2024, up $0.5 million from Q3 2023.Gross Margin: 73
Revenue: $1.9 million for Q2 2024, down from $2.9 million in Q2 2023.US E-commerce Revenue: $1.3 million for Q2 2024, up from $1.2 million in Q2 2023.Internati
New York, March 02, 2021 (GLOBE NEWSWIRE) -- - Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) signs deal with Neo Performance Materials to launch rare ...